People with HIV do not have a higher or lower risk for severe COVID-19 than the general population and should receive a similar treatment approach, according to a study published in The Lancet HIV. People living with HIV (PLWH) “should not be considered protected from SARS-CoV-2 infection or as having lower risk of severe disease,” Pilar Vizcarra, MD, of the department of infectious
Approximately 77,000 people in the U.S. have hypoparathyroidism due to absent or subphysiological levels of parathyroid hormone. About 75% of cases are the result of…
ATLANTA — Pregnant women with fewer economic resources may still be at elevated risk for CVD despite a low score on a CVD risk calculator,…
ATLANTA — Data from a small substudy with cardiac MRI suggest acoramidis may improve both cardiac mass and function for adults with symptomatic transthyretin amyloid…
As the eye care world approaches a possible shortage of ophthalmologists, the steady hand of robotic surgical tools could be a welcome addition for patients…
The American Society of Nephrology has called on Congress to increase funding for the U.S. transplant system by $8 million in fiscal year 2025, according…
The FDA has approved subcutaneous administration of Takeda Pharmaceuticals’ Entyvio for maintenance therapy in adult patients with moderate-to-severe Crohn’s disease following induction therapy via IV…
BOSTON — More than 40% of patients with difficult-to-treat pathogens were prescribed older, generic agents despite the FDA approval of several new gram-negative antibiotics, findings…
BOSTON — “We should be embracing [AI] and trying to make this a priority to get this right, because I don’t know any alternative to…
Sublingual immunotherapy tablets improved quality of life for patients with allergic rhinitis with and without conjunctivitis, according to a review published in The Journal of…
BOSTON — Time-restricted eating did not result in more weight loss vs. a usual eating pattern, suggesting that overall caloric intake may have a larger…
